PhD candidate in Pharmacoepidemiology
University of Basel, Switzerland, Switzerland
Luis Velez-Nandayapa, MD, MSc, PhD candidate
Clinical development professional with a background in clinical development phase I to IV as Medical Monitor/ Clinical Scientist.
Management of Pharmacovigilance process as Safety Management Team Leader in clinical trials and post-marketing involving signal detection/ management, risk management activities related to the preparation and maintenance of Risk Management Plans and aggregate reports.
Involved in Real World Evidence and Pharmacoepidemiology studies at the Pharmacoepidemiology Unit at the University of Basel.
Medical Doctor and General Surgeon from the Universidad Nacional Autonóma de México.
Master in Science in Pharmacovigilance from the Drug Safety Research Unit and the University of Portsmouth, UK.
Currently, PhD candidate from the Pharmacoepidemiology Unit at the University of Basel, Switzerland. Dissertation topic: Glaucoma.